Global Endoscope + Radiofrequency Ablation (RFA) Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Radiofrequency ablation (RFA) is one of the most promising ablative techniques for BE. The technique uses a bipolar electrode that is available as a balloon-based device for primary circumferential ablation or as a cap-based device that can be mounted on the tip of the endoscope for focal ablation.
According to our (Global Info Research) latest study, the global Endoscope + Radiofrequency Ablation (RFA) market size was valued at USD 3678.7 million in 2022 and is forecast to a readjusted size of USD 5234.5 million by 2029 with a CAGR of 5.2% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The key factors that boost the growth of the global endoscope + radiofrequency ablation (RFA) market include upsurge in demand for novel treatment methods for patients suffering from cancer, cardiovascular diseases, and disorders associated with chronic pain along with the benefits offered by this advanced treatment modality. Several research studies have concluded that radiofrequency ablation (RFA) treatment efficiently creates lesion in the targeted body parts while maintaining short procedure durations.
This report is a detailed and comprehensive analysis for global Endoscope + Radiofrequency Ablation (RFA) market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Endoscope + Radiofrequency Ablation (RFA) market size and forecasts, in consumption value ($ Million), 2018-2029
Global Endoscope + Radiofrequency Ablation (RFA) market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Endoscope + Radiofrequency Ablation (RFA) market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Endoscope + Radiofrequency Ablation (RFA) market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Endoscope + Radiofrequency Ablation (RFA)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Endoscope + Radiofrequency Ablation (RFA) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Boston Scientific Corporation Conmed Corporation, Medtronic Plc (Covidien Plc), Smith and Nephew Plc, Stryker Corporation and Halyard Health, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Endoscope + Radiofrequency Ablation (RFA) market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
    Focal Ablation
    Others
Market segment by Application
    Cardiology Application
    Pain Management
    Oncology Application
    Other Application
Market segment by players, this report covers
    Boston Scientific Corporation Conmed Corporation
    Medtronic Plc (Covidien Plc)
    Smith and Nephew Plc
    Stryker Corporation
    Halyard Health
    Abbott Laboratories (St. Jude Medical, Inc.)
    AngioDynamics
    Hologic
    AtriCure
Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Endoscope + Radiofrequency Ablation (RFA) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Endoscope + Radiofrequency Ablation (RFA), with revenue, gross margin and global market share of Endoscope + Radiofrequency Ablation (RFA) from 2018 to 2023.
Chapter 3, the Endoscope + Radiofrequency Ablation (RFA) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Endoscope + Radiofrequency Ablation (RFA) market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Endoscope + Radiofrequency Ablation (RFA).
Chapter 13, to describe Endoscope + Radiofrequency Ablation (RFA) research findings and conclusion.